PT1052991E - Utilizacao de loperamida para o tratamento de infeccoes microbianas - Google Patents

Utilizacao de loperamida para o tratamento de infeccoes microbianas

Info

Publication number
PT1052991E
PT1052991E PT99904829T PT99904829T PT1052991E PT 1052991 E PT1052991 E PT 1052991E PT 99904829 T PT99904829 T PT 99904829T PT 99904829 T PT99904829 T PT 99904829T PT 1052991 E PT1052991 E PT 1052991E
Authority
PT
Portugal
Prior art keywords
treatment
loperamid
microbial infections
infections
microbial
Prior art date
Application number
PT99904829T
Other languages
English (en)
Inventor
Carol Keene
Angus Malcolm
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT1052991E publication Critical patent/PT1052991E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PT99904829T 1998-02-05 1999-01-29 Utilizacao de loperamida para o tratamento de infeccoes microbianas PT1052991E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802542.2A GB9802542D0 (en) 1998-02-05 1998-02-05 New use

Publications (1)

Publication Number Publication Date
PT1052991E true PT1052991E (pt) 2003-08-29

Family

ID=10826560

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99904829T PT1052991E (pt) 1998-02-05 1999-01-29 Utilizacao de loperamida para o tratamento de infeccoes microbianas

Country Status (9)

Country Link
US (1) US6566374B1 (pt)
EP (1) EP1052991B1 (pt)
AT (1) ATE236633T1 (pt)
DE (1) DE69906701T2 (pt)
DK (1) DK1052991T3 (pt)
ES (1) ES2196769T3 (pt)
GB (1) GB9802542D0 (pt)
PT (1) PT1052991E (pt)
WO (1) WO1999039711A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use
US7220800B2 (en) * 2004-04-02 2007-05-22 Adherent Laboratories, Inc. Water soluble contact lens blocking composition with absorbent disintegrant
US7138459B2 (en) * 2004-04-02 2006-11-21 Adherent Laboratories, Inc. Water soluble contact lens blocking composition
WO2007003941A1 (en) * 2005-07-06 2007-01-11 Cambridge Enterprise Limited Modulation of autophagy by calpain inhibition
US20080033021A1 (en) * 2006-08-02 2008-02-07 Susan Burke Wash composition for the handling of contact lenses
FR2969494B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906779A1 (de) 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6156771A (en) * 1997-08-28 2000-12-05 Rubin; Walter Method for alleviation of lower gastrointestinal disorders in a human patient
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use

Also Published As

Publication number Publication date
GB9802542D0 (en) 1998-04-01
EP1052991A1 (en) 2000-11-22
ES2196769T3 (es) 2003-12-16
WO1999039711A1 (en) 1999-08-12
US6566374B1 (en) 2003-05-20
DK1052991T3 (da) 2003-08-04
DE69906701D1 (de) 2003-05-15
EP1052991B1 (en) 2003-04-09
ATE236633T1 (de) 2003-04-15
DE69906701T2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
HK1206361A1 (en) Modified 2 and 3 -nucleoside produgs for treating flaviridae infections 2 3-
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
MXPA02000282A (es) Composiciones de cuidado personal.
DE60010456D1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
BR9706949A (pt) Composições desinfetantes e processos para desinfecção de superfícies
BR9706945A (pt) Composições desinfetantes e processos para disinfecção de superfícies
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
DE69628302D1 (de) Milchige reinigungs- und/oder desinfektionsmittelzusammensetzungenfür harte oberflächen.
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
SE9904377D0 (sv) Pharmaceutical combinations
BR9707610A (pt) Composições desinfetantes e processos para desinfecção de superfícies
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
IL143280A0 (en) Use of riluzole for treating acoustic traumas
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
FR2802101B1 (fr) Association de cymemazine et d'un neuroleptique atypique